A2 still owns a chunk of SML, so wouldn't have thought would do too much to the detriment of that - except if the growth opportunities with Fonterra outweigh the value of their shareholding.....
Printable View
There might be an initial knee jerk reaction from market but in the long run it does matter as Synlait does most of the Infant Formula requirements whereas the agreement with Fonterra is more for Fresh Milk and A1 free Protein Free Supplements.
Moreover remember its Synlait that hold the CFDA approval which is the main key.
I've just placed an order for a few more. May as well apply my ATM "profits" to something
wow this looks like it could be heading to fill the 590 gap, if this falls through 620 could be a real possibility.